Navigation Links
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Date:1/24/2013

December 3120122011Cash flows from operating activities:  Net income$
94,732$
32,189  Adjustments to reconcile net income to net cash provided byoperating activities:Depreciation and amortization117,708105,214Non-cash impairment charges41,73612,119Non-cash compensation expense associated with employee benefitand stock compensation plans40,75940,057Deferred income tax benefit(8,404)(6,128)Gain on sale of investment(1,459)-Loss on sale of business169-Loss on disposal of property and equipment1,1811,618Equity investee earnings(17)(480)Changes in operating assets and liabilities, net of businesses soldand acquired:Accounts receivable(28,541)(50,754)Unbilled services(23,419)(23,366)Inventory10,9188,226Accounts payable(1,963)2,297Accrued liabilities8,20556,409Unearned revenue54,99815,909Income taxes(10,522)(21,070)Other assets and liabilities, net(35,920)(28,762)Net cash provided by operating activities260,161243,478Cash flows from investing activities:  Capital expenditures(151,679)(134,633)  Proceeds from sale of investment4,682-  Other, net1,017(219)Net cash used in investing activities(145,980)(134,852)Cash flows from financing activities:  Net borrowings (repayments) under revolving credit facility290,000(5,000)  Repayments under long-term debt-(97,500)  Stock issued under employee stock purchase and option plans13,7729,325  Purchase of treasury stock(323,773)(8,810)Net cash used in financing activities(20,001)(101,985)Effect of exchange rate changes on cash9,5415,239Net change in cash and cash equivalents103,72111,880Cash and cash equivalents, beginning of period389,103377,223Cash and cash equivalents, end of period$
492,824$
389,103 COVANCE INC.GAAP to Pro Forma ReconciliationQ4 2012(Dollars in thousands, except per share data)(UNAUDITED)AdjustmentsGAAP Restructuring Activities (1)Other
Items (2)Operating Results at Sites Wound-Down (3)Pro FormaNet revenues$
5
'/>"/>
SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
2. Covance Reports Second Quarter Pro Forma Net Revenue Of $538 Million, Pro Forma EPS Of $0.65 And Adjusted Net Orders Of $701 Million
3. Covance to Present at the Morgan Stanley Global Healthcare Conference
4. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
5. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... 2014 The Brandeis Medical Center, led by Dr. Emmanuel ... and affordable laser tattoo removal experience with the advanced Astanza Duality ... providing high quality cosmetic services with cutting edge medical technology and ... Southern California has seen a dramatic increase in the ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... a privately held personalized medicine company focused on cancer, ... C (GCC) Lymph Nodes (LN) Classification as a Prognostic ... Pooled Analysis" at the 2012 American Society of Clinical ... 21, 2012.  The data from the paper demonstrate the ...
... 23, 2012 InspireMD, Inc. (OTC BB: NSPR) (the ... the development and commercialization of its proprietary stent platform ... today announced its business objectives for 2012 and reviewed ... the Company,s proprietary MicroNet™ platform technology. ...
Cached Medicine Technology:Signal Genetics Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstageā„¢ GCC Confirming Prognostic Capabilities in Patients with Colon Cancer 2InspireMD Provides Corporate Update, Plans for 2012 2InspireMD Provides Corporate Update, Plans for 2012 3InspireMD Provides Corporate Update, Plans for 2012 4InspireMD Provides Corporate Update, Plans for 2012 5InspireMD Provides Corporate Update, Plans for 2012 6
(Date:4/17/2014)... chronic inflammation in benign prostate tissue was associated ... association was found even in those with low ... published in Cancer Epidemiology, Biomarkers & Prevention ... Cancer Research. , An analysis of prostate tissue ... arm of the Prostate Cancer Prevention Trial (PCPT) ...
(Date:4/17/2014)... popular vaccine brands for children may not be the ... cost factors when choosing vaccines, driving the market toward ... a new study by University of Illinois researchers. , ... by numerous factors," says Sheldon H. Jacobson, a co-author ... and of mathematics at the U. of I. "In ...
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... about one in five infants in the United States ... first several months after birth. Research into probiotic use ... the April 1, 2014 issue of the British ... study, "Probiotics and Infant Colic," concluding that the use ... colic did not reduce crying or fussing in ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... SXC Health Solutions, Inc.,("SXC" or the "Company") (NASDAQ: ... of,pharmacy benefits management services, announces that Mark Thierer,President ... Vice President,and Chief Financial Officer, will present at ... Grand Hyatt in New York City. SXC,s presentation,will ...
... Bermuda, Jan. 28 Warner Chilcott,Limited (Nasdaq: WCRX ) ... Total revenues for 2008 are expected to be in the ... driven by LOESTRIN 24 FE, DORYX,FEMCON FE, and TACLONEX. Gross ... be in the range of 80% to 81% in 2008., ...
... While many of today,s seniors are,retiring into what ... of life,they want to stay connected to the "real ... to trustworthy information and resources. In,addition, these adults are ... referrals for home repairs to coordinating personal,transportation and even ...
... NTY ), (http://www.NBTY.com ), a leading global manufacturer ... fiscal first quarter ended,December 31, 2007., For the ... were,$511 million compared to $506 million for the fiscal ... million or 1%., Net income for the fiscal ...
... Demo 08 -- Today, at DEMO 08,Acesis Inc. ... a,revolutionary on-demand electronic health record software solution. Acesis,Point-of-Care ... professionals by providing a secure, intuitive data capture,system ... "Acesis Point-of-Care is a striking example of ...
... 10 a.m. EST, January 28, 2008, WALTHAM, Mass., ... and Matria Healthcare, Inc. (Nasdaq: MATR ) today,announced ... to,which Inverness will acquire all outstanding shares of common ... cash plus $32.50 in,convertible preferred stock of Inverness (convertible ...
Cached Medicine News:Health News:SXC Health Solutions to present at the 2008 UBS Global Healthcare Services Conference 2Health News:Warner Chilcott Announces 2008 Financial Guidance 2Health News:Warner Chilcott Announces 2008 Financial Guidance 3Health News:Warner Chilcott Announces 2008 Financial Guidance 4Health News:Warner Chilcott Announces 2008 Financial Guidance 5Health News:Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates 2Health News:Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates 3Health News:NBTY Reports First Quarter Results 2Health News:NBTY Reports First Quarter Results 3Health News:NBTY Reports First Quarter Results 4Health News:NBTY Reports First Quarter Results 5Health News:NBTY Reports First Quarter Results 6Health News:NBTY Reports First Quarter Results 7Health News:NBTY Reports First Quarter Results 8Health News:NBTY Reports First Quarter Results 9Health News:NBTY Reports First Quarter Results 10Health News:NBTY Reports First Quarter Results 11Health News:NBTY Reports First Quarter Results 12Health News:NBTY Reports First Quarter Results 13Health News:NBTY Reports First Quarter Results 14Health News:Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 2Health News:Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 3Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 2Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 3Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 4Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 5Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 6
... higher magnification and increased stereopsis, the Central ... visualization to the equatorial regions. The Central ... and in membrane peeling in proliferative vitreoretinopathy ... Lenses The ACS Vitrectomy Lenses from Volk ...
... the high resolution, high magnification and field ... simple two part design separates for easy ... Simply autoclave, add saline or water to ... use. (ACS) AutoClave Sterilizable Lenses The ACS ...
... These patented ACS lenses offer the ... view as the original clariVits. The simple ... while maintaining its integrity during surgery. Simply ... contact element, then lock together for use. ...
... over a wide field ... entire retina, detailed retinal ... tears, diagnosis and treatment ... the vitreous cavity is ...
Medicine Products: